Search

everythinglearnresearchcommunity

for

Search:↓

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Topical estrogens improved hair growth in about half of the patients.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Trilostane treatment led to full hair regrowth in most Pomeranians and all miniature poodles with alopecia X.

Birth control pills are effective for treating women with too much male hormone.

Spironolactone is effective and safe for treating acne with minimal side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.